Swedish regional population-based organised prostate cancer testing: why, what and how?

Objective: This study aimed to describe the regional, population-based, organised prostate cancer testing (OPT) programmes that are being introduced throughout Sweden: motives, structure, target population, diagnostic algorithm, quality control, outcomes, research, and future perspectives. Result...

Full description

Bibliographic Details
Published in:Scandinavian Journal of Urology
Main Authors: Ola Bratt, Salma Tunå Butt, Charlotte Carlsson, Lisa Jelf-Eneqvist, Olof Gunnarsson, Alma Ihre, Thomas Jiborn, Anna Lantz, Heide Larsson, Helena Strömqvist, Johan Styrke, Nils-Erik Svedberg, Rebecka Arnsrud Godtman
Format: Article
Language:English
Published: Medical journals sweden AB 2025-06-01
Subjects:
Online Access:https://medicaljournalssweden.se/SJU/article/view/43809
_version_ 1849492189876322304
author Ola Bratt
Salma Tunå Butt
Charlotte Carlsson
Lisa Jelf-Eneqvist
Olof Gunnarsson
Alma Ihre
Thomas Jiborn
Anna Lantz
Heide Larsson
Helena Strömqvist
Johan Styrke
Nils-Erik Svedberg
Rebecka Arnsrud Godtman
author_facet Ola Bratt
Salma Tunå Butt
Charlotte Carlsson
Lisa Jelf-Eneqvist
Olof Gunnarsson
Alma Ihre
Thomas Jiborn
Anna Lantz
Heide Larsson
Helena Strömqvist
Johan Styrke
Nils-Erik Svedberg
Rebecka Arnsrud Godtman
author_sort Ola Bratt
collection DOAJ
container_title Scandinavian Journal of Urology
description Objective: This study aimed to describe the regional, population-based, organised prostate cancer testing (OPT) programmes that are being introduced throughout Sweden: motives, structure, target population, diagnostic algorithm, quality control, outcomes, research, and future perspectives. Results: In 2018, the Swedish National Board of Health and Welfare renewed their recommendation against screening for prostate cancer. Despite this, regional OPT was considered motivated to (1) improve cost-effectiveness compared with unorganised testing, (2) improve equity by giving every man in the target population a chance to make an informed choice, and (3) gain diagnostic and organisational knowledge. The OPT programmes are provided as a regional public healthcare service. They are coordinated by a national working group. The final target population is all men aged 50–74 years. Regional OPT offices use a national administrative system to organise all steps from sending invitation letters to prostate biopsy according to a strict diagnostic algorithm. General practice is involved for blood draw only or not at all. Data are registered in a national register (SweOPT); an annual report is published with the regions’ performance on key indicators. At the end of 2024, 16 of the 21 Swedish regions had started OPT and invited 256,000 men with an average cumulative participation rate of 43%. A consortium co-ordinates OPT-related research. A general experience is that communication and organisational matters have been more challenging than medical decisions. Conclusions: The Swedish population-based OPT programmes provide organisational experiences, diagnostic outcomes, and research results of value for future national prostate cancer screening programmes.
format Article
id doaj-art-0131a6dbc35c43bc967e8d537bc9ff13
institution Directory of Open Access Journals
issn 2168-1813
language English
publishDate 2025-06-01
publisher Medical journals sweden AB
record_format Article
spelling doaj-art-0131a6dbc35c43bc967e8d537bc9ff132025-08-20T03:07:38ZengMedical journals sweden ABScandinavian Journal of Urology2168-18132025-06-016010.2340/sju.v60.43809Swedish regional population-based organised prostate cancer testing: why, what and how?Ola Bratt0Salma Tunå Butt1Charlotte Carlsson2Lisa Jelf-Eneqvist3Olof Gunnarsson4Alma Ihre5Thomas Jiborn6Anna Lantz7Heide Larsson8Helena Strömqvist9Johan Styrke10Nils-Erik Svedberg11Rebecka Arnsrud Godtman12Department of Urology, Sahlgrenska University Hospital, Göteborg, SwedenDepartment of Surgery, Skåne University Hospital, Lund University, SwedenRegional Cancer Centre South East, Linköping, SwedenRegional Cancer Centre Stockholm-Gotland, Stockholm, SwedenDepartment of Urology, Ryhov County Hospital, Jönköping, SwedenRegional Cancer Centre West, Gothenburg, SwedenDepartment of Urology, Helsingborg Hospital, Helsingborg, SwedenDepartment of Pelvic Cancer, Karolinska University Hospital, Stockholm, SwedenRegional Cancer Centre Mid-Sweden, Uppsala, SwedenRegional Cancer Centre North, Västerbotten County Council, Umeå, SwedenRegional Cancer Centre North, Västerbotten County Council, Umeå, SwedenRegional Cancer Centre Mid-Sweden, Uppsala, SwedenDepartment of Urology, Sahlgrenska University Hospital, Göteborg, Sweden Objective: This study aimed to describe the regional, population-based, organised prostate cancer testing (OPT) programmes that are being introduced throughout Sweden: motives, structure, target population, diagnostic algorithm, quality control, outcomes, research, and future perspectives. Results: In 2018, the Swedish National Board of Health and Welfare renewed their recommendation against screening for prostate cancer. Despite this, regional OPT was considered motivated to (1) improve cost-effectiveness compared with unorganised testing, (2) improve equity by giving every man in the target population a chance to make an informed choice, and (3) gain diagnostic and organisational knowledge. The OPT programmes are provided as a regional public healthcare service. They are coordinated by a national working group. The final target population is all men aged 50–74 years. Regional OPT offices use a national administrative system to organise all steps from sending invitation letters to prostate biopsy according to a strict diagnostic algorithm. General practice is involved for blood draw only or not at all. Data are registered in a national register (SweOPT); an annual report is published with the regions’ performance on key indicators. At the end of 2024, 16 of the 21 Swedish regions had started OPT and invited 256,000 men with an average cumulative participation rate of 43%. A consortium co-ordinates OPT-related research. A general experience is that communication and organisational matters have been more challenging than medical decisions. Conclusions: The Swedish population-based OPT programmes provide organisational experiences, diagnostic outcomes, and research results of value for future national prostate cancer screening programmes. https://medicaljournalssweden.se/SJU/article/view/43809Prostate cancerorganised testingscreeningpopulation-baseddiagnosticsquality control
spellingShingle Ola Bratt
Salma Tunå Butt
Charlotte Carlsson
Lisa Jelf-Eneqvist
Olof Gunnarsson
Alma Ihre
Thomas Jiborn
Anna Lantz
Heide Larsson
Helena Strömqvist
Johan Styrke
Nils-Erik Svedberg
Rebecka Arnsrud Godtman
Swedish regional population-based organised prostate cancer testing: why, what and how?
Prostate cancer
organised testing
screening
population-based
diagnostics
quality control
title Swedish regional population-based organised prostate cancer testing: why, what and how?
title_full Swedish regional population-based organised prostate cancer testing: why, what and how?
title_fullStr Swedish regional population-based organised prostate cancer testing: why, what and how?
title_full_unstemmed Swedish regional population-based organised prostate cancer testing: why, what and how?
title_short Swedish regional population-based organised prostate cancer testing: why, what and how?
title_sort swedish regional population based organised prostate cancer testing why what and how
topic Prostate cancer
organised testing
screening
population-based
diagnostics
quality control
url https://medicaljournalssweden.se/SJU/article/view/43809
work_keys_str_mv AT olabratt swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow
AT salmatunabutt swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow
AT charlottecarlsson swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow
AT lisajelfeneqvist swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow
AT olofgunnarsson swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow
AT almaihre swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow
AT thomasjiborn swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow
AT annalantz swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow
AT heidelarsson swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow
AT helenastromqvist swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow
AT johanstyrke swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow
AT nilseriksvedberg swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow
AT rebeckaarnsrudgodtman swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow